Determine the necessary mass, volume, or concentration for preparing a solution.
Zansecimab (anti-ANGPT2) (Ab175707) - SEC
The purity of Zansecimab (anti-ANGPT2) (Ab175707) is more than 95% verified by HPLC.
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab175707-100μg | 100μg | In stock | $59.90 | |
Ab175707-1mg | 1mg | In stock | $279.90 | |
Ab175707-5mg | 5mg | In stock | $739.90 | |
Ab175707-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,189.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Zansecimab (anti-ANGPT2) - Primary antibody, specific to ANGPT2, >95%, high purity, Human IgG4SP |
---|---|
Synonyms | AGPT 2 antibody; Agpt2 antibody; ANG 2 antibody; ANG-2 antibody; ANG2 antibody; Angiopoietin 2a antibody; Angiopoietin 2B antibody; Angiopoietin-2 antibody; Angiopoietin2 antibody; ANGP2_HUMAN antibody; ANGPT 2 antibody; Angpt2 antibody; Tie2 ligand antib |
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Specificity | ANGPT2 |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | INHIBITOR |
Mechanism of action | INHIBITOR of Angiopoietin-2 inhibitor |
Product Description | Zansecimab (anti-ANGPT2) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab (anti-ANGPT2) has potential applications in angiogenesis and immune regulation. |
Isotype | Human IgG4SP |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 145.24 kDa |
Purification Method | Protein A purified |
Purity | >95% |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 2415205-37-5 |
Zansecimab (anti-ANGPT2) (Ab175707) - SEC
The purity of Zansecimab (anti-ANGPT2) (Ab175707) is more than 95% verified by HPLC.
Zansecimab (anti-ANGPT2) (Ab175707) - ELISA
Immobilized hANGPT2-chis at 2.0 μg/mL can bind Zansecimab (anti-ANGPT2) (Ab175707) with the EC₅₀ of 14.91 ng/mL.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IMGT/mAb-DB | 1112 |
---|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0102658 | Certificate of Analysis | Jan 30, 2024 | Ab175707 |
ZJ24F0102657 | Certificate of Analysis | Jan 30, 2024 | Ab175707 |
ZJ24F0102659 | Certificate of Analysis | Jan 30, 2024 | Ab175707 |
1. Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J et al.. (2016) Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.. EMBO Mol Med, 8 (11): (1265-1288). [PMID:27742718] |
2. Maisonpierre, P C PC and 13 more authors.. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.. Science (New York, N.Y.), (4): [PMID:9204896] |
3. Tanaka, S S and 5 more authors.. (1999) Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma.. The Journal of clinical investigation, [PMID:9927494] |
4. Kim, I I and 5 more authors.. (2000) Characterization and expression of a novel alternatively spliced human angiopoietin-2.. The Journal of biological chemistry, (16): [PMID:10766762] |
5. Fiedler, Ulrike U and 8 more authors.. (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats.. The Journal of biological chemistry, (17): [PMID:12427764] |
6. Lee, Hyuek Jong HJ and 9 more authors.. (2004) Biological characterization of angiopoietin-3 and angiopoietin-4.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, [PMID:15284220] |
7. Barton, William A WA, Tzvetkova, Dorothea D and Nikolov, Dimitar B DB.. (2005) Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.. Structure (London, England : 1993), [PMID:15893672] |
8. Nusbaum, Chad C and 75 more authors.. (2006) DNA sequence and analysis of human chromosome 8.. Nature, (19): [PMID:16421571] |
9. Barton, William A WA and 6 more authors.. (2006) Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.. Nature structural & molecular biology, [PMID:16732286] |
10. Yacyshyn, Orisha K OK and 5 more authors.. (2009) Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.. Angiogenesis, [PMID:19116766] |
11. Yuan, Hai Tao HT, Khankin, Eliyahu V EV, Karumanchi, S Ananth SA and Parikh, Samir M SM.. (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.. Molecular and cellular biology, [PMID:19223473] |
12. Leppänen, Veli-Matti and 20 more authors.. (2020) Characterization of ANGPT2 mutations associated with primary lymphedema.. Science translational medicine, (9): [PMID:32908006] |